SCHEMBL16406799

SCHEMBL16406799

c1ccc(-c2cc(-c3cccc4c3sc3ccccc34)nc(-c3cccc(-n4c5ccccc5c5c6sc7ccccc7c6ccc54)c3)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.35
MAPT P10636 3/20 0.32
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
LMNA P02545 2/20 0.32
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
CYP1A2 P05177 2/20 0.31
CYP2C9 P11712 2/20 0.31
CYP2C19 P33261 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
CYP3A4 P08684 1/20 0.31
GAA P10253 1/20 0.31
AGTR1 P30556 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
PRKDC P78527 3/20 0.31
MAPK10 P53779 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16811694 0.96 ALOX5 (0.35) ALOX5MAPTMEN1KMT2ALMNA
SCHEMBL10014513 0.95 MAPT (0.35) ALOX5MAPTMEN1KMT2ALMNA
SCHEMBL16811582 0.92 ALOX5 (0.38) ALOX5MAPTMEN1KMT2ALMNA
SCHEMBL16811587 0.92 ALOX5 (0.38) ALOX5MAPTMEN1KMT2ALMNA
SCHEMBL10014514 0.92 MEN1 (0.35) ALOX5MAPTMEN1KMT2ALMNA
SCHEMBL16811688 0.92 ALOX5 (0.39) ALOX5MAPTMEN1KMT2ALMNA
SCHEMBL17586358 0.91 MAPT (0.33) ALOX5MAPTMEN1KMT2ALMNA
SCHEMBL21925397 0.91 ALOX5 (0.33) ALOX5MAPTMEN1KMT2ALMNA
SCHEMBL16811540 0.90 MEN1 (0.34) ALOX5MAPTMEN1KMT2ALMNA
SCHEMBL18564428 0.90 KDM4E (0.33) ALOX5MAPTMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210226134-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO LTD (KR) 2021-07-22 US disclosed
US-10985329-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-04-20 US disclosed
US-20190074451-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO LTD (KR) 2019-03-07 US disclosed
US-20150171340-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2015-06-18 US disclosed
US-20150171340-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2015-06-18 US disclosed
US-20150025239-A1 NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME AHN HEE-CHOON (KR) 2015-01-22 US disclosed
US-20150025239-A1 NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME AHN HEE-CHOON (KR) 2015-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210226134-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNE2, CRY2 ALOX5 1964/4885MAPT 1656/4885MEN1 880/4885
US-10985329-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CCNE2, CRY2 ALOX5 1964/4885MAPT 1656/4885MEN1 880/4885
US-20190074451-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNE2, CRY2 ALOX5 1964/4885MAPT 1656/4885MEN1 880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.